1. Home
  2. ULH vs ENTA Comparison

ULH vs ENTA Comparison

Compare ULH & ENTA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Universal Logistics Holdings Inc.

ULH

Universal Logistics Holdings Inc.

N/A

Current Price

$13.89

Market Cap

390.3M

Sector

Industrials

ML Signal

N/A

Logo Enanta Pharmaceuticals Inc.

ENTA

Enanta Pharmaceuticals Inc.

HOLD

Current Price

$14.41

Market Cap

382.7M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
ULH
ENTA
Founded
1932
1995
Country
United States
United States
Employees
N/A
N/A
Industry
Trucking Freight/Courier Services
Biotechnology: Pharmaceutical Preparations
Sector
Industrials
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
390.3M
382.7M
IPO Year
2004
2012

Fundamental Metrics

Financial Performance
Metric
ULH
ENTA
Price
$13.89
$14.41
Analyst Decision
Hold
Strong Buy
Analyst Count
1
5
Target Price
$20.00
$20.40
AVG Volume (30 Days)
50.2K
236.1K
Earning Date
05-12-2026
05-11-2026
Dividend Yield
1.74%
N/A
EPS Growth
N/A
29.93
EPS
N/A
N/A
Revenue
$1,461,708,000.00
$102,814,000.00
Revenue This Year
$2.73
$7.76
Revenue Next Year
$5.12
N/A
P/E Ratio
N/A
N/A
Revenue Growth
N/A
16.48
52 Week Low
$11.73
$6.44
52 Week High
$30.76
$17.15

Technical Indicators

Market Signals
Indicator
ULH
ENTA
Relative Strength Index (RSI) 37.64 59.39
Support Level $13.05 $13.19
Resistance Level $18.76 $15.48
Average True Range (ATR) 1.02 0.76
MACD -0.13 0.22
Stochastic Oscillator 8.35 74.04

Price Performance

Historical Comparison
ULH
ENTA

About ULH Universal Logistics Holdings Inc.

Universal Logistics Holdings Inc is an asset-light provider of customized transportation and logistics solutions throughout the United States, and in Mexico, Canada, and Colombia. It offers services such as truckload, brokerage, intermodal, dedicated, and value-added services. The firm has three reportable segments, namely contract logistics, intermodal, and trucking. The company generates the key revenue from Contract Logistics, which provides value-added and dedicated transportation services to support inbound and internal logistics requirements of industrial manufacturers and retailers, generally under contractual arrangements of one year or longer. Geographically, the firm generates the majority of its revenue from the United States, followed by Mexico, Canada, and Colombia.

About ENTA Enanta Pharmaceuticals Inc.

Enanta Pharmaceuticals Inc is a biotechnology company that uses a chemistry-based drug discovery approach to develop small-molecule candidates for virology and immunology applications. It focuses on Virology and Immunology. Its active development programs in virology are focused on respiratory syncytial virus, or RSV, and SARS-CoV-2, and Hepatitis B virus. In immunology, the company is engaged in designing and developing potent and selective, oral small molecule inhibitors for the treatment of type 2 inflammatory disease. The company has collaborated with AbbVie, which markets its protease inhibitor paritaprevir, with additional inhibitors in development. The company generates the majority revenue in the form of royalty revenue.

Share on Social Networks: